Evaluation of Bioequivalence of Two Oral Formulations of Olanzapine
Olanzapine is an atypical antipsychotic drug, used for the management of schizophrenia and for the treatment of moderate to severe mania associated with bipolar disorder. The objective of the present randomised, crossover study was to compare the bioavailability of olanzapine 10 mg/5 ml powder for o...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Medknow Publications & Media Pvt Ltd
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480756/ |